| Stimulation of collateral artery growth: a potential treatment for peripheral artery disease. | |
| | |
MedLine Citation:
|
PMID: 15225117 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
In the course of peripheral artery occlusive disease, blood flow to peripheral tissue progressively decreases in a substantial portion of patients, leading to insufficient oxygenation and to the occurrence of claudication or critical limb ischemia. Arteriogenesis (collateral artery growth) is a powerful natural mechanism by which large conductance vessels develop that circumvent sites of obstruction. Promising experimental data on both hypoxia-driven angiogenesis as well as monocyte-orchestrated arteriogenesis have raised high hopes for clinical application. Both endothelial growth factors to stimulate angiogenesis (i.e., capillary growth) and monocyte-attracting or -activating substances to stimulate arteriogenesis, have been proposed as potential new therapeutic agents. However, transferring the promising experimental results into clinical practice has been more cumbersome than initially anticipated. Some recent clinical studies are now focusing more specifically on the stimulation of arteriogenesis. This review will critically evaluate the results of preclinical and clinical investigations on the stimulation of vascular growth, focusing specifically on the peripheral circulation. |
| | |
Authors:
|
Stephan H Schirmer; Niels van Royen |
Related Documents
:
|
6650047 - Arteriographic, doppler and surgical evaluation of aorto iliac disease and arterial ins... 12601197 - Detection of atherosclerosis: systemic imaging for systemic disease with whole-body thr... 12546587 - Vascular endothelial growth factor (vegf165) and its influence on angiogenesis versus a... 11369077 - Prescribing, recording, and reporting in endovascular brachytherapy. quality assurance,... 9168397 - Modeling of flow in a straight stented and nonstented side wall aneurysm model. 655117 - Isolated dissecting aneurysm of the renal artery. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Expert review of cardiovascular therapy Volume: 2 ISSN: 1744-8344 ISO Abbreviation: Expert Rev Cardiovasc Ther Publication Date: 2004 Jul |
Date Detail:
|
Created Date: 2004-06-30 Completed Date: 2007-10-05 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101182328 Medline TA: Expert Rev Cardiovasc Ther Country: England |
Other Details:
|
Languages: eng Pagination: 581-8 Citation Subset: IM |
Affiliation:
|
Department of Internal Medicine III-Cardiology and Angiology, University Hospital Freiburg, Germany. Schirmer@med1.ukl.uni-freiburg.de |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Arterial Occlusive Diseases
/
etiology,
physiopathology,
therapy* Collateral Circulation / physiology* Fibroblast Growth Factor 2 / physiology Gene Transfer Techniques Humans Peripheral Vascular Diseases / etiology, physiopathology, therapy* Vascular Endothelial Growth Factor A / physiology |
| Chemical | |
Reg. No./Substance:
|
0/Vascular Endothelial Growth Factor A; 103107-01-3/Fibroblast Growth Factor 2 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Implantable cardioverter defibrillators in children.
Next Document: Recent advances in minimal-access cardiac surgery using robotic-enhanced surgical systems.